Drug · DIN 02268396
APO-SUMATRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 24, 2005; first marketed August 24, 2005.
- Drug Identification Number (DIN)
- 02268396
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- September 3, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 24, 2005: NOC 7319Abbreviated New Drug Submission (ANDS)
Other DINs named APO-SUMATRIPTAN
- DIN 02268388 · Marketed
- DIN 02282313 · Approved
- DIN 02300567 · Approved
- DIN 02300575 · Approved